{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:39:56Z","timestamp":1789688396683,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK058831"],"award-info":[{"award-number":["DK058831"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK087843"],"award-info":[{"award-number":["DK087843"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX000319"],"award-info":[{"award-number":["BX000319"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.trsl.2022.10.001","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T07:05:51Z","timestamp":1665644751000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4"],"prefix":"10.1016","volume":"253","author":[{"given":"Lu","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man J.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2022.10.001_bib0001","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2022.10.001_bib0002","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/ijms20123011","article-title":"Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury","volume":"20","author":"Holditch","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.10.001_bib0003","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1681\/ASN.2020101455","article-title":"Potential therapeutic targets for cisplatin-induced kidney injury: lessons from other models of AKI and fibrosis","volume":"32","author":"Sears","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","article-title":"Mitochondrial quality control in kidney injury and repair","volume":"17","author":"Tang","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1681\/ASN.2021121591","article-title":"Cisplatin-induced kidney injury: delivering the goods","volume":"33","author":"Curry","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0006","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.trsl.2022.10.001_bib0007","doi-asserted-by":"crossref","unstructured":"Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism, Cancer Metab, 2, 2014, 2.https:\/\/cancerandmetabolism.biomedcentral.com\/articles\/10.1186\/2049-3002-2-2 Accessed January 23, 2014.","DOI":"10.1186\/2049-3002-2-2"},{"key":"10.1016\/j.trsl.2022.10.001_bib0008","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.3390\/cells10112913","article-title":"Canonical and non-canonical roles of PFKFB3 in brain tumors","volume":"10","author":"Alvarez","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2022.10.001_bib0009","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-022-04803-y","article-title":"IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis","volume":"13","author":"Song","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.10.001_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.jbchem.a021719","article-title":"Characterization of a human placental fructose-6-phosphate, 2-kinase\/fructose-2,6-bisphosphatase","volume":"122","author":"Sakakibara","year":"1997","journal-title":"J Biochem"},{"key":"10.1016\/j.trsl.2022.10.001_bib0011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41419-018-0435-y","article-title":"PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT","volume":"9","author":"Shi","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.10.001_bib0012","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41388-017-0072-4","article-title":"Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4","volume":"37","author":"Jia","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2022.10.001_bib0013","doi-asserted-by":"crossref","first-page":"24223","DOI":"10.1074\/jbc.M109.016816","article-title":"Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases","volume":"284","author":"Yalcin","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2022.10.001_bib0014","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1002\/ctm2.324","article-title":"IL-22-mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.trsl.2022.10.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113939","article-title":"Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms","volume":"177","author":"Kim","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0016","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1073\/pnas.1424313112","article-title":"Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4\/6 and OCT2 functions","volume":"112","author":"Pabla","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.10.001_bib0017","doi-asserted-by":"crossref","first-page":"F379","DOI":"10.1152\/ajprenal.00475.2013","article-title":"CDK4\/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury","volume":"306","author":"DiRocco","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ki.1996.295","article-title":"Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats","volume":"50","author":"Woost","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2022.10.001_bib0019","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.113.303041","article-title":"Endothelial PFKFB3 plays a critical role in angiogenesis","volume":"34","author":"Xu","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0020","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","article-title":"Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor","volume":"66","author":"Rankin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2022.10.001_bib0021","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension","volume":"116","author":"Cao","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.10.001_bib0022","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1172\/JCI45586","article-title":"Inhibition of PKCdelta reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer","volume":"121","author":"Pabla","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2022.10.001_bib0023","doi-asserted-by":"crossref","first-page":"F1282","DOI":"10.1152\/ajprenal.00230.2007","article-title":"Activation and involvement of p53 in cisplatin-induced nephrotoxicity","volume":"293","author":"Wei","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0024","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1172\/JCI121859","article-title":"MicroRNA-668 represses MTP18 to preserve mitochondrial dynamics in ischemic acute kidney injury","volume":"128","author":"Wei","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2022.10.001_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040712","article-title":"p53 in proximal tubules mediates chronic kidney problems after cisplatin treatment","volume":"11","author":"Fu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2022.10.001_bib0026","first-page":"1","article-title":"Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis","author":"Livingston","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.trsl.2022.10.001_bib0027","doi-asserted-by":"crossref","first-page":"F1041","DOI":"10.1152\/ajprenal.00512.2019","article-title":"Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity","volume":"318","author":"Song","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.trsl.2022.10.001_bib0028","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2022.10.001_bib0029","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.kint.2018.11.042","article-title":"Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease","volume":"95","author":"Landau","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2022.10.001_bib0030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molcel.2019.03.020","article-title":"Cyclin D-Cdk4,6 drives cell-cycle progression via the retinoblastoma protein's C-terminal helix","volume":"74","author":"Topacio","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2022.10.001_bib0031","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/MCB.19.3.2251","article-title":"Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice","volume":"19","author":"Tong","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0032","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-018-0749-z","article-title":"Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury","volume":"565","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.10.001_bib0033","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1681\/ASN.2015020177","article-title":"Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI","volume":"27","author":"Lan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0034","article-title":"Glucose metabolism in acute kidney injury and kidney repair","volume":"8","author":"Wen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.trsl.2022.10.001_bib0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2021050680","article-title":"Decreased renal gluconeogenesis is a hallmark of chronic kidney disease","volume":"33","author":"Verissimo","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0036","doi-asserted-by":"crossref","first-page":"F455","DOI":"10.1152\/ajprenal.00111.2021","article-title":"Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice","volume":"321","author":"Osada","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0037","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41581-022-00592-x","article-title":"Immunometabolic rewiring of tubular epithelial cells in kidney disease","volume":"18","author":"van der Rijt","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0038","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/cancers13040909","article-title":"Role of PFKFB3 and PFKFB4 in cancer: genetic basis, impact on disease development\/progression, and potential as therapeutic targets","volume":"13","author":"Kotowski","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trsl.2022.10.001_bib0039","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3892\/ijmm.2014.1828","article-title":"Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury","volume":"34","author":"Wang","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.trsl.2022.10.001_bib0040","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.2006020162","article-title":"Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2","volume":"17","author":"Price","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0041","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1046\/j.1523-1755.2001.00044.x","article-title":"Positive effect of the induction of p21WAF1\/CIP1 on the course of ischemic acute renal failure","volume":"60","author":"Megyesi","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2022.10.001_bib0042","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1681\/ASN.2014050463","article-title":"MicroRNA-687 induced by hypoxia-inducible factor-1 targets Phosphatase and Tensin homolog in renal ischemia-reperfusion injury","volume":"26","author":"Bhatt","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0043","doi-asserted-by":"crossref","first-page":"F52","DOI":"10.1152\/ajprenal.00119.2007","article-title":"Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo","volume":"293","author":"Yu","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.trsl.2022.10.001_bib0044","doi-asserted-by":"crossref","first-page":"F1171","DOI":"10.1152\/ajprenal.00507.2010","article-title":"Cdk2-dependent phosphorylation of p21 regulates the role of Cdk2 in cisplatin cytotoxicity","volume":"300","author":"Hodeify","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2020.08.020","article-title":"Integrating Old and New Paradigms of G1\/S Control","volume":"80","author":"Rubin","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2022.10.001_bib0046","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2022.10.001_bib0047","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-14-0816","article-title":"Molecular pathways: targeting the cyclin D-CDK4\/6 axis for cancer treatment","volume":"21","author":"VanArsdale","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2022.10.001_bib0048","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/cc.11.3.19062","article-title":"Drosophila cyclin D\/Cdk4 regulates mitochondrial biogenesis and aging and sensitizes animals to hypoxic stress","volume":"11","author":"Icreverzi","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2022.10.001_bib0049","doi-asserted-by":"crossref","first-page":"e1337","DOI":"10.1038\/cddis.2014.292","article-title":"6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27","volume":"5","author":"Yalcin","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.10.001_bib0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/14728222.2018.1498082","article-title":"The potential utility of PFKFB3as a therapeutic target","volume":"22","author":"Bartrons","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.trsl.2022.10.001_bib0051","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13046-016-0481-1","article-title":"Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma","volume":"36","author":"Li","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.trsl.2022.10.001_bib0052","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/1535-7163.MCT-13-0097","article-title":"Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer","volume":"12","author":"Clem","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.trsl.2022.10.001_bib0053","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41416-022-01867-7","article-title":"PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM","volume":"127","author":"Sarkar Bhattacharya","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2022.10.001_bib0054","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/cancers13143604","article-title":"PFKFB3 Inhibition sensitizes DNA crosslinking chemotherapies by suppressing Fanconi anemia repair","volume":"13","author":"Ninou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trsl.2022.10.001_bib0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41467-018-02950-5","article-title":"Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.10.001_bib0056","doi-asserted-by":"crossref","first-page":"14531","DOI":"10.1038\/s41598-020-71475-z","article-title":"Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2022.10.001_bib0057","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.trsl.2022.10.001_bib0058","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.2337\/diabetes.51.11.3290","article-title":"Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy","volume":"51","author":"Feliers","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2022.10.001_bib0059","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMoa2114663","article-title":"Overall survival with Ribociclib plus Letrozole in advanced breast cancer","volume":"386","author":"Hortobagyi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2022.10.001_bib0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41523-021-00311-y","article-title":"Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer","volume":"7","author":"Spring","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.trsl.2022.10.001_bib0061","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41467-021-25422-9","article-title":"Co-targeting CDK4\/6 and AKT with endocrine therapy prevents progression in CDK4\/6 inhibitor and endocrine therapy-resistant breast cancer","volume":"12","author":"Alves","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.10.001_bib0062","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lungcan.2022.02.010","article-title":"Phase Ib\/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer","volume":"166","author":"Santoro","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.trsl.2022.10.001_bib0063","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41585-022-00571-8","article-title":"Therapeutic potential of CDK4\/6 inhibitors in renal cell carcinoma","volume":"19","author":"Sager","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.trsl.2022.10.001_bib0064","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-21-4302","article-title":"A phase Ib\/II study of the CDK4\/6 inhibitor ribociclib in combination with docetaxel plus prednisone in metastatic castration-resistant prostate cancer","volume":"28","author":"de Kouchkovsky","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422002201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422002201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:48:05Z","timestamp":1761828485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524422002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":64,"alternative-id":["S1931524422002201"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.10.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}